HPD — A Study of Its Components and Their Properties

  • R. Bonnett
  • M. C. Berenbaum
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 160)


The phototoxic effect (“photodynamic action”) of administered porphyrin in mammals appears to have been first observed by Hausmann (1) in mice and by Meyer-Betz (2) in man. The effect was known in certain porphyrias long before this, but the cause was not known. The localisation of administered porphyrins in tumour tissue was recognised (3) in the 1940s, and this behaviour was explored further in the 1950s in work that led to the development of the HPD preparation (4,5). It was not until 1972 that these two ideas concerning the biological activity of porphyrins (that is, photode-gradation of tissue and localisation in tumours) came together successfully, when Diamond and his colleagues (6) demonstrated that a porphyrin could be used to photosen-sitise the preferential degradation of tumour implants in the rat. In 1975 this result was confirmed and extended by Berenbaum and his colleagues (7), and by Dougherty and his colleagues (8).


Dimethyl Sulphoxide Evans Blue Dimethyl Ester Preparative Separation Photodynamic Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    W. Hausmann, Biochem. Z., 1911, 30, 276.Google Scholar
  2. 2.
    F. Meyer-Betz, Deutsch. Arch. Klin. Med., 1913, 112, 476.Google Scholar
  3. 3.
    H. Auler and G. Banzer, Z. Krebforsch., 1942, 53, 65;CrossRefGoogle Scholar
  4. 3a.
    F.H.J. Figge, G.S. Weiland, and L.O. Manganiello, Proc. Soc. Exp. Biol. Med., 1948, 64, 640.Google Scholar
  5. 4.
    S. Schwartz, K. Absolon, and H. Vermund, Univ. Minnesota Med. Bull., 1955, 27, 7.Google Scholar
  6. 5.
    R.L. Lipson and E.J. Baldes, Arch. Dermatol., 1960, 82, 508;PubMedCrossRefGoogle Scholar
  7. 5a.
    R.L. Lipson, E.J. Baldes, and A.M. Olsen, J. Natl. Cancer Inst., 1961, 26, 1.PubMedGoogle Scholar
  8. 6.
    I. Diamond, A.F. McDonagh, C.B. Wilson, S.G. Granelli, S. Nielsen, and R. Jaenicke, Lancet, 1972, ii, 1175.CrossRefGoogle Scholar
  9. 7.
    J.F. Kelly, M.E. Snell, and, M.C. Berenbaum, Brit. J. Cancer, 1975, 31, 237.PubMedCrossRefGoogle Scholar
  10. 8.
    T.J. Dougherty, G.B. Grindey, R. Fiel, K.R. Weishaupt, and D.G. Boyle, J. Natl. Cancer Inst., 1975, 55, 115.PubMedGoogle Scholar
  11. 9.
    R. Bonnett, A.A. Charalambides, K. Jones, I.A. Magnus, and R.J. Ridge, Biochem. J., 1978, 173, 693.PubMedGoogle Scholar
  12. 10.
    R. Bonnett, R.J. Ridge, P.A. Scourides, and M.C. Berenbaum, J. Chem. Soc. Chem. Comm., 1980, 1198.Google Scholar
  13. 11.
    R. Bonnett, R.J. Ridge, P.A. Scourides, and M.C. Berenbaum, J. Chem. Soc. Perkin Trans I, 1981, 3135.Google Scholar
  14. 12.
    P. Clezy, T.T. Hai, R.W. Henderson, and L. van Thuc, Aust. J. Chem., 1980,33,545.CrossRefGoogle Scholar
  15. 13.
    R. Bonnett, A.A. Charalambides, E.J. Land, R.S. Sinclair, D. Tait, and T.G. Truscott, J. Chem. Soc. Faraday I, 1980,76, 452.CrossRefGoogle Scholar
  16. 14.
    R.S. Sinclair, D. Tait, and T.G. Truscott, J. Chem. Soc. Faraday I, 1980, 76, 417.CrossRefGoogle Scholar
  17. 15.
    M.C. Berenbaum, R. Bonnett, R.J. Ridge, and P.A. Scourides, Abstracts, Tetrapyrrole Discussion Group, Glasgow, September 26th 1980.Google Scholar
  18. 16.
    M.C. Berenbaum, R. Bonnett, and P.A. Scourides, Br. J. Cancer, 1982, In Press.Google Scholar
  19. 17.
    R. Bonnett, C.R. Lambert, E.J. Land, P.A. Scourides, R.S. Sinclair, and T.G. Truscott, in preparation.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • R. Bonnett
    • 1
  • M. C. Berenbaum
    • 2
  1. 1.Department of ChemistryQueen Mary CollegeLondonUK
  2. 2.Wellcome Laboratories of Experimental Pathology, Variety Club Research WingSt. Mary’s Hospital Medical SchoolLondonUK

Personalised recommendations